Competitive Intelligence Excellence: Structure, Reporting, CI Evolution and Best Practices

STUDY OVERVIEW

When done well, the Competitive Intelligence (CI) function helps companies make better decisions, anticipate threats, plan effectively in a rapidly changing market, and avoid corporate risk. But the non-traditional CI function is often undervalued in corporations, and CI leaders can often find themselves struggling for attention and resources.

Included in the research study are benchmarks for the size, structure, reporting tools and best practices that drive effectiveness in high-performing CI organizations. This study also identifies the 10 key Hallmarks of Competitive Intelligence Excellence and presents insights from interviews with veteran CI leaders on how to evolve the CI role from data gathering to providing strategic advice for decision makers.

Best Practices, LLC conducted this research project to identify best practices and innovative methods for improving the strategic role and impact of the Competitive Intelligence function within the pharmaceutical and related industries.

KEY TOPICS

• Structure & Reporting
• CI Evolution & Trends
• Best Practices & Lessons Learned

• Effective methods for measuring internal customers/stakeholders satisfaction
• Steps taken to promote functional value to corporation
• Steps taken to encourage greater usage from internal customers
• Top 5 most effective methods for delivering insights to internal customers
• Success factors for CI organizations
• Steps to propel CI employees from data gatherers to strategic advisors
• Gaining a voice in commercial issues and decisions
• Key best practices identified by the benchmark class
• Lessons learned for delivering value to brand teams & other key customers

• Use of Advisory Boards to Collect CI Is Shrinking: The use of Ad Boards is down significantly from previous BPLLC studies, where as many as 90% of respondents engaged them to gather intelligence. In this study, only 52% collect intelligence from advisory boards, and only 21% find them highly effective for primary research.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.